Anastasia A. Kachanova
2/1 Barrikadnaya St
Moscow, MOW 123242, Russian Federation
Moscow, MOW 123242, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.
Journal: International journal of molecular sciences
Published: April 07, 2026
Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort.
Journal: Genes
Published: October 08, 2025
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Journal: Drug metabolism and personalized therapy
Published: February 07, 2023
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Journal: Drug metabolism and personalized therapy
Published: February 07, 2023
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Journal: Pharmacogenetics and genomics
Published: October 18, 2022
Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome
Journal: Terapevticheskii arkhiv
Published: June 16, 2022
The Influence of ABCB1 (rs1045642 and rs4148738) Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Aged 80 Years and Older with Nonvalvular Atrial Fibrillation.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: May 06, 2022
Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma.
Journal: Drug metabolism and personalized therapy
Published: March 08, 2022
CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups
Journal: Terapevticheskii arkhiv
Published: January 27, 2022
Effect of CYP2C9, PTGS-1 and PTGS-2 gene polymorphisms on the efficiency and safety of postoperative analgesia with ketoprofen.
Journal: Drug metabolism and personalized therapy
Published: December 05, 2021
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
Journal: Drug metabolism and personalized therapy
Published: April 07, 2021
Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation
Journal: Terapevticheskii arkhiv
Published: September 01, 2020
Last Updated: 09/26/2026